Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients

Sponsor
The Cleveland Clinic (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05725928
Collaborator
National Institute on Aging (NIA) (NIH)
3,000
2
42.3

Study Details

Study Description

Brief Summary

The investigator proposes to conduct a randomized trial of supervised ambulation delivered by mobility technician (MT) up to three times daily, including weekends, to hospitalized medical patients. The aims of the study are to compare the short and intermediate-term outcomes of patients randomized to the intervention versus those patients randomized to receive usual care, to identify patients who are most likely to benefit from the intervention and to assess whether the intervention increases or decreases overall costs of an episode of care, including the cost of the MTs, the index hospitalization and the first 30 days post enrollment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mobility technician
N/A

Detailed Description

The investigator proposes to conduct a large randomized trial to test the impact of MTs (Mobility Technicians) on short and intermediate term outcomes for 3000 patients aged 65 years and older at 5 hospitals in 2 health systems. Patients will be randomized to receive supervised ambulation up to 3 times daily with a MT or to receive usual care. All participants will wear an accelerometer on their wrist to track their movement throughout the hospital stay. The study has 3 aims. First, the study will compare the mobility of patients at discharge (or 10 days) to assess the impact of the MTs on this outcome. Of particular interest is whether the use of MTs will increase the proportion of patients who can go home vs.post-acute care, and whether the improvements in mobility are sustained at 30 days. Second, the study will use predictive modeling to identify which patients are most likely to benefit from this intervention. Third, the study will assess the impact of the intervention on overall costs associated with the episode of care, including inpatient costs and the 30 days post enrollment. This information will be important to convince health systems to adopt this approach.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Randomized Trial of Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
Anticipated Study Start Date :
Apr 3, 2023
Anticipated Primary Completion Date :
Sep 11, 2026
Anticipated Study Completion Date :
Oct 11, 2026

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

No intervention

Experimental: Mobility Technician

Designated mobility technicians (MT) will ambulate hospitalized medical patients up to 3 times daily, 7 days per week, until discharge or a maximum of 10 days. Each day, the MT will visit the patient 4 times or until the patient successfully ambulates 3 times that day. In cases where a PT has provided a recommendation in the patient's chart, the MT will follow the recommendation, if feasible. Otherwise, the MT will execute the standard mobility protocol. The mobility protocol will allow the MT to assist a patient with an appropriate out-of-bed activity based on their 6-clicks score from the immediately preceding session

Behavioral: Mobility technician
Designated mobility technicians (MT) will ambulate hospitalized medical patients up to 3 times daily, 7 days per week, until discharge or a maximum of 10 days. Each day, the MT will visit the patient 4 times or until the patient successfully ambulates 3 times that day. In cases where a PT has provided a recommendation in the patient's chart, the MT will follow the recommendation, if feasible. Otherwise, the MT will execute the standard mobility protocol. The mobility protocol will allow the MT to assist a patient with an appropriate out-of-bed activity based on their 6-clicks score from the immediately preceding session.

Outcome Measures

Primary Outcome Measures

  1. Change in Short Physical Performance Battery (SPPB) from admission [Up to 10 days]

    Every patient will have an SPPB score on admission to the study. A blinded assessor will measure the SPPB again at discharge or on day 10 if the patient is still hospitalized. The primary outcome is change from admission to discharge. Investigators will also compare the percentage of patients who reach the minimal clinically important difference of 1 point. SPPB minimum value= 0 SPPB maximum value= 12 (higher score indicates a better outcome)

Secondary Outcome Measures

  1. Patient-Reported Outcomes Measurement Information System (PROMIS) physical function - mobility [30 days post enrollment]

    Patients will complete the PROMIS physical function mobility bank via REDCap at 30 days post enrollment. PROMIS allows use of computer-adapted testing to measure patient-reported outcomes. The mobility question bank focuses on activities of physical mobility such as getting out of bed or a chair to walking up stairs. PROMIS measures were developed and validated with state-of-the-science methods supported by National Institutes of Health (NIH) funding. PROMIS was designed to enhance communication between clinicians and patients in diverse research and clinical settings and to be relevant across all conditions for the assessment of symptoms and functions. PROMIS minimum value= 0 PROMISE maximum value= 100 (higher score indicates a better outcome)

  2. Activity Measure for Post-Acute Care (AM-PAC) basic mobility outpatient short form (SF) [30 days post enrollment]

    Subjects will complete the AM-PAC at 30 days post enrollment and the score will be transformed using the t-scale. In addition to comparing AM-PAC scores at 30 days, the investigator will also compare change in t-score from admission. The AM-PAC 6-clicks (assessed in the hospital) and the AM-PAC outpatient SF are normed to the same t-scale, allowing for conversion from the one to the other. The 6-clicks is scored by a clinical proxy, while the SF AM-PAC is self-reported, allowing for initial assessment by the MT and 30-day self-report by the patient. Previous studies have demonstrated adequate validity of mobility assessment via the AM-PAC using clinical or family proxies. To improve interpretability, investigators will compare the percentage of patients who reach the minimal clinically important difference of 3 points on the t-scale. AM-PAC minimum value= 29.41 AM-PAC maximum value= 80.30 (higher score indicates a better outcome)

  3. Hospital-Acquired Complications [10 days]

    Composite outcome of venous thromboembolism, fall with injury, pressure ulcers or hospital-acquired pneumonia. Hospital-acquired complications will be identified from the electronic health record and from the falls reporting system. All falls will be examined, whether occurring during assisted ambulation or otherwise. Only falls with injury will be included in the hospital-acquired complications measure. Outcomes will be adjudicated by blinded reviewers. While investigators are primarily interested in the composite measure, investigators will also examine the individual components separately.

  4. Number of Patients with Readmission within 30 days [30 days after discharge]

    All cause readmission within 30 days of discharge from the index hospitalization.

  5. Activities of Daily Living [30 days post enrollment]

    Activities of daily living as measured by the Katz and Lawton scales. Katz minimum value= 0 Katz maximum value= 6 (higher score indicates a better outcome) Lawton minimum value= 0 Lawton maximum value= 8 (higher score indicates a better outcome)

  6. Frailty [30 days post enrollment]

    Frailty as measured by the Fatigue, Resistance, Ambulation,Illness, and Loss of weight (FRAIL) scale. FRAIL minimum value= 0 FRAIL maximum value= 5 (higher score indicates a worse outcome)

  7. Total episode cost [Admission to 30 days post enrollment]

    Investigators will estimate total cost of the episode of care including the index admission (from hospital cost accounting systems), the personnel costs for the MTs (using hourly wages plus benefits), and all non-medication costs for the 30 days post-enrollment (from Medicare claims).

  8. Number of Patients Discharged to Home [date of randomization to date of discharge, up to 30 days]

    Based on the discharge disposition in the medical record, investigators will identify whether the patient was discharged to home.

  9. Length of Stay [date of admission to date of discharge, up to 30 days]

    Length of stay will be calculated as whole days from the time of admission to the time of discharge.

  10. Mortality [30 days from admission]

    Patient's vital status will be ascertained from the EHR, Medicare claims or from follow-up phone calls.

  11. Total episode cost [Admission to 6 months after enrollment]

    Investigators will estimate total cost of the episode of care including the index admission (from hospital cost accounting systems), the personnel costs for the MTs (using hourly wages plus benefits), and all non-medication costs for the 6 months post-enrollment (from Medicare claims).

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Participants must meet all of the inclusion criteria listed below to participate in this study:

  1. ≥65 years of age

  2. Admitted to a medical service

  3. Complete history and physical examination on file

  4. 6-Clicks score of 16-20

  5. Insurance with Traditional Medicare or Medicare Advantage

Exclusion Criteria:

Any patient meeting any of the exclusion criteria listed below at baseline will be excluded from study participation:

  1. Significant language barrier that requires a translator (other than Spanish at Baystate site only)

  2. Discharge planned for that day or the following day

  3. Observation status

  4. Surgical procedure planned

  5. Patients diagnosed with unstable angina or other medical conditions precluding participation in exercise/ambulation

  6. Permanent residence in a skilled nursing facility

  7. Comfort care measures only

  8. 48 hours since admission

  9. Active infection with COVID-19

  10. Other active infection requiring contact or droplet precautions

  11. Order for bedrest

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The Cleveland Clinic
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Michael Rothberg, M.D., The Cleveland Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Michael Rothberg, Vice Chair for Research, Primary Care Institute, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT05725928
Other Study ID Numbers:
  • 22-426
  • 1R01AG073278-01A1
First Posted:
Feb 13, 2023
Last Update Posted:
Feb 13, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 13, 2023